Clinical Trials
208 trialsNOECHO
Skribe Medical
A Study of Blood Pressure Control During Cancer Treatment
Memorial Sloan Kettering Cancer Center
C-BREAST-01
Gazi University
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
G-COR
The Cleveland Clinic
SPARTACUS
Icahn School of Medicine at Mount Sinai
CMR-Onko
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography
Yonsei University
STOP-MED CTRCD
University Health Network, Toronto
BREATHS
University College, London
PCT
Abramson Cancer Center at Penn Medicine
SENTINEL
Abramson Cancer Center at Penn Medicine
ML-CardioTox
University Hospital, Caen
PULSE
Dana-Farber Cancer Institute
Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.
Sun Yat-sen University
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
University of Chicago
CARE-BREAST
University of Castilla-La Mancha
CVE-CART
Abramson Cancer Center at Penn Medicine
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
Abramson Cancer Center at Penn Medicine
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Abramson Cancer Center at Penn Medicine
SCARA-B
Centre Paul Strauss
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
Ottawa Hospital Research Institute
BE-FITTER
University of Alberta
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
BRAVE-HEART
Fondazione IRCCS Policlinico San Matteo di Pavia
OTT 15-05
Ottawa Hospital Research Institute
ROSUBREAST
Shiraz University of Medical Sciences
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
Taichung Veterans General Hospital
HIMALAYAS-P
University Health Network, Toronto
HIMALAYAS
University Health Network, Toronto
EMPACT
Maria Sklodowska-Curie National Research Institute of Oncology
ATOPE
Universidad de Granada
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
CARDIOTOX
Oncology Institute of Southern Switzerland
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
CCT2
Abramson Cancer Center at Penn Medicine
Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
Connecticut Children's Medical Center
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Medical College of Wisconsin
CCTGuide Pilot
Abramson Cancer Center at Penn Medicine
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
CLARITY
Abramson Cancer Center at Penn Medicine
CARD-IO
Royal Marsden NHS Foundation Trust
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
Memorial Sloan Kettering Cancer Center
DAPA-AIC
Hawler Medical University
Cardio CAR-T
Assistance Publique - Hôpitaux de Paris
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
DETECT
Assistance Publique - Hôpitaux de Paris
Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity
West China Second University Hospital
PROACT
Washington University School of Medicine